MEDICINE WITHOUT MEDS
Transforming
Patient Care with
Digital Therapies
Get your copy
Technology Alone Cannot Transform Healthcare
We Empower
Practice-Changing Healthcare
MEDICINE WITHOUT MEDS
Transforming
Patient Care with
Digital Therapies
Get your copy
Technology Alone Cannot Transform Healthcare
We Empower
Practice-Changing Healthcare
MEDICINE WITHOUT MEDS
Transforming
Patient Care with
Digital Therapies
Get your copy
Technology Alone Cannot Transform Healthcare
We Empower
Practice-Changing Healthcare

WisDM.CTI

Clinical Trials Innovation

WisDM. N.1Tx

Therapeutics / Interventional

WisDM. N.1Dx

Diagnostics / Wearables

WisDM.Data

Data Infrastructure

WisDM.Enable

Development of HIVE

5

Key
Themes

vision of

Digital Medicine

Empowering practice-changing medicine through in-house technologies and partnerships

WATCH VIDEO Play Video

Clinical Trials

Know more about

Our Team

Prof. Goh Boon Cher

Oncology

Research Interests

Lung Cancer
Head & Neck Cancer
Phase I Clinical Trials

Prof. Dean Ho

Director,
Biomedical Engineering

Research Interests

Artificial Intelligence
Personalized Medicine
Digital Medicine

A/Prof Ngiam Kee Yuan

Deputy Director,
Endocrine & Thyroid Surgery

Research Interests

Health Information Technology
Artificial Intelligence
Surgical Oncology

Giving Your Support

Discover how donations have opened up opportunities in Digital Medicine.

explore our latest

News

2025
Scientists use microcellular drones to deliver lung cancer-killing drugs

A team of researchers, led by Assistant Professor Minh Le from the Institute for Digital Medicine (WisDM) and Department of Pharmacology at the Yong L...


More Details >
2024
医研所所长:运动再多饮食不节制 代谢难启动

新加坡国立大学杨潞龄医学院数码医学研究所所长何鼎教授(45岁),以自己为实验对象,严格进行七个月的间歇�...


More Details >
2024
Modified nano-sized cell particles boost cancer immunotherapy, reduce side effects

A team led by Assistant Professor Minh Le from the Institute for Digital Medicine (WisDM) and Department of Pharmacology at the Yong Loo Lin School of...


More Details >
stay updated with our

Twitter Feeds